Endothelin - A receptor antagonist BQ123 protects against myocardial and endothelial reperfusion injury

G. Szabó, S. Bährte, L. Fazekas, D. MacDonald, N. Stumpf, Ch F. Vahl, S. Hagl

Research output: Contribution to journalArticle

13 Citations (Scopus)


Background: This study was designed to investigate the effects of the selective endothelin-A receptor antagonist BQ123 on myocardial and endothelial function after reversible deep hypothermic ischemia and reperfusion. Methods: Isogenic intra-abdominal heterotopic heart transplantation was performed in Lewis rats. After one hour of cold ischemic preservation reperfusion was started after application of either saline vehicle or BQ123 (1 μmol/L). Left-ventricular pressure-volume relations and myocardial blood flow were assessed after one and 24 hours of reperfusion. Responses to endothelium-dependent vasodilator acetylcholine and endothelium- independent vasodilator sodium nitroprusside were also determined. Results: BQ123 significantly improved myocardial contractility, as indicated by the leftward shift of the systolic pressure-volume relation and significantly increased myocardial blood flow during early reperfusion (p < 0.05). Although myocardial function and baseline myocardial blood flow were similar in both groups after 24 hours of reperfusion, endothelium-dependent vasodilatation was still significantly higher in the BQ123 group (p < 0.05). Conclusions: These results suggest that endothelin-A receptor antagonists may be useful in reducing ischemia/reperfusion injury after heart transplantation by preservation of myocardial and endothelial function.

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalThoracic and Cardiovascular Surgeon
Issue number4
Publication statusPublished - Aug 1998


  • Contractile function
  • Endothelial function
  • Endothelian antagonist
  • Heart transplantation
  • Reperfusion

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Endothelin - A receptor antagonist BQ123 protects against myocardial and endothelial reperfusion injury'. Together they form a unique fingerprint.

  • Cite this